Agilent Technologies, Inc. (A) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Diagnostics & Research Branche. Der Hauptsitz des Unternehmens ist in Santa Clara, CA, United States. Der aktuelle CEO ist Padraig McDonnell.
A hat IPO-Datum 1999-11-18, 17,900 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $34.05B.
Agilent Technologies, Inc. is a global provider of analytical instruments, software, and services serving the life sciences, diagnostics, and applied chemical markets. The company operates through three primary segments: Life Sciences and Applied Markets, which offers chromatography and mass spectrometry systems, spectroscopy instruments, and cell analysis technologies; Diagnostics and Genomics, which provides genomic arrays, next-generation sequencing solutions, and diagnostic reagents; and Agilent CrossLab, which supplies consumables, columns, and comprehensive laboratory support services. Agilent's products enable customers to accelerate innovation and solve critical challenges in drug discovery, clinical diagnostics, food safety, and environmental testing. The company distributes its solutions worldwide through direct sales, distributors, resellers, and digital channels.